Aryaman Pharmaceuticals Private Limited
About Aryaman Pharmaceuticals Private Limited
Data last updated:
Aryaman Pharmaceuticals Private Limited was a private limited company based in Pune, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the film production and entertainment segment of the entertainment sector. It was incorporated on 10 July 2009.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U46497PN2009PTC134298.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Suman Prabhakar Palwe and Charudatta Prabhakar Palwe.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Off No 302 A City Bay Sr No. A/3C/1 A/1 348 A/1/1 F.P., Pune, Maharashtra, India – 411001.
Its group structure includes 1 subsidiary.
Company details
CIN history
Aryaman Pharmaceuticals has one previous CIN (Corporate Identification Number): U74900PN2009PTC134298. The current CIN is U46497PN2009PTC134298, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46497PN2009PTC134298 | Current |
| U74900PN2009PTC134298 | Previous |
Contact details
Aryaman Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOff No 302 A City Bay Sr No. A/3C/1 A/1 348 A/1/1 F.P., Pune, Maharashtra, India – 411001
- IndustryEntertainment, Motion Picture, Sound Recording And Music Publishing, Video And Television Programme Production
To see the full contact details of Aryaman Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aryaman Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aryaman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aryaman Pharmaceuticals Private Limited
Aryaman Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Prabhakar Palwe | Additional Director | 05 Dec 2024 | 1 Years 11 Months | As last reported |
| Charudatta Prabhakar Palwe Also directs: Tribeca Realty and Trading Services LLP, Palwe Associates LLP, GTT Data Solutions Limited and 5 more | Additional Director | 05 Dec 2024 | 1 Years 11 Months | As last reported |
Auditor
Aryaman Pharmaceuticals Private Limited is audited by V. Singhi & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. Singhi & Associates | FY 2017 | 311017E |
Shareholding
The shareholding of Aryaman Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aryaman Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aryaman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aryaman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Aryaman Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Supra Media Private Limited | U74999PN2011PTC140601 |
To see the full group structure of Aryaman Pharmaceuticals Private Limited, buy the company report.
GST
No GST registration is on our record for Aryaman Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aryaman Pharmaceuticals Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Charudatta Prabhakar Palwe was appointed as Additional Director on 05 Dec 2024.
Frequently asked questions
Aryaman Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Aryaman Pharmaceuticals was a private limited company based in Pune, Maharashtra, India. The company worked in motion picture, within the entertainment industry. It was incorporated on 10 July 2009 and is registered under CIN U46497PN2009PTC134298. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Aryaman Pharmaceuticals is U46497PN2009PTC134298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aryaman Pharmaceuticals had 2 directors:
- Suman Prabhakar Palwe - Additional Director
- Charudatta Prabhakar Palwe - Additional Director
Aryaman Pharmaceuticals was incorporated on 10 July 2009. It is registered with the Registrar of Companies, Pune.
The registered office of Aryaman Pharmaceuticals is at Off No 302 A City Bay Sr No. A3C1 A1 348 A11 F.P., Pune, Maharashtra, India – 411001.
The latest financial statements of Aryaman Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
Aryaman Pharmaceuticals operated in the entertainment industry, in the motion picture segment.
Charudatta Prabhakar Palwe was appointed as Additional Director on 05 Dec 2024. Prabhakar Supada Palve ceased to be Additional Director on 05 Dec 2024. Suman Prabhakar Palwe was appointed as Additional Director on 05 Dec 2024. Aryaman Pharmaceuticals has 6 board changes on record in total.
The compliance status of Aryaman Pharmaceuticals is compliant as of 27 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
